Pfizer (PFE)

EBITDA Growth

-69.27%

Quarterly · Period ending:

PFE logo

PFE EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-69.27%
PFE Quarterly EBITDA YoY % (14.84% → -69.27%)
High-resolution chart · PNG

PFE ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer EBITDA Growth — Quarterly
Period endingEBITDA Growth
35.7109%
28.0842%
74.3695%
37.4861%
4.4709%
84.9688%
74.4352%
50.8389%
92.6316%
24.5393%
-12.8497%
24.9476%
26.3603%
-1.2452%
4.6638%
1.8143%
21.6176%
14.7253%
17.9632%
20.6386%
8.4703%
21.9022%
34.4573%
33.6833%
34.9042%
17.2636%
308.6504%
12.9911%
-24.6595%
15.7665%
-166.019%
8.9638%
82.0006%
15.8904%
31.6693%
8.5327%
9.783%
9.3318%
20.0824%
12.8764%
16.4027%
19.7241%
108.3165%
-73.2221%
-79.6423%
-74.7615%
-6.788%
4.0205%
-2.5217%
10.6634%
-11.151%
6.549%
8.9072%
15.9253%
-14.8891%
11.5897%
9.7683%
8.4779%
-12.7864%
14.84%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.